Company: MIRA
Filing Date: 2025-07-08
Form Type: 8-K
Source: 0001641172-25-018247
Chunk: 0

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-07-08
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item       Other    

On
July 3, 2025, MIRA Pharmaceuticals, Inc. (the “ Company”), sold a total of 1,550,741 shares of its common stock, par value
$0.001, in block sales to an institutional investor, at an average price of $1.2981 share (a premium to the prior days close), through
its at-the-market equity offering facility (the “ Offering”). Gross proceeds from the Offering totalled approximately $2.0
million, prior to deducting fees and expenses. The trades for the Offering were facilitated through Rodman & Renshaw, via the StockBlock
platform. The Offering did not include any warrants.

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                    MIRA                                         
  Dated:            By:                       /s/                
                    Name:                     Erez               
                    Title:                    Chief